Control of T cell response during respiratory infection
呼吸道感染期间 T 细胞反应的控制
基本信息
- 批准号:6674905
- 负责人:
- 金额:$ 25.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-15 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:Poxviridae disease T lymphocyte anergy antigen antibody reaction antigen presenting cell bioterrorism /chemical warfare cellular immunity emerging infectious disease enzyme linked immunosorbent assay flow cytometry genetically modified animals green fluorescent proteins host organism interaction immunoregulation laboratory mouse leukocyte activation /transformation lung organ culture pulmonary respiration respiratory infections suppressor T lymphocyte vaccinia virus vector vaccine virus infection mechanism virus load
项目摘要
DESCRIPTION (provided by applicant): There is an emerging threat of the use of respiratory pathogens as weapons of bioterrorism. Thus it is imperative that we understand the interaction of viral pathogens with the immune response in the specialized microenvironment of the lung. Although a number of pathogens pose a threat, of particular concern is variola virus. Infection with variola virus results not only in significant morbidity, but in significant fatality. As a result of the eradication of smallpox, the vaccine was discontinued in 1973, leaving those under the age of 30 unprotected. In addition there is significant concern regarding the length of time protection is sustained following immunization, such that older individuals are also likely to be susceptible to infection and disease. Surprisingly in spite of the development of an effective vaccine for variola virus, many questions remain in our basic understanding of the interaction of this virus with the host immune response. We have developed a model for respiratory infection with vaccinia virus, the closely related virus used in the vaccine against smallpox. An advantage of the studies in this application is that they focus on the immune response following intranasal infection, the natural route by which variola virus is obtained and a likely route of inoculation for agents of bioterrorism. The studies in this application build on our published novel observation that the CD8+T cell response following intranasal infection of mice with a high dose of vaccinia virus is severely decreased compared to mice receiving 100-fold less virus. The goal of the studies proposed herein is the identification of the mechanism(s) responsible for the decreased T cell response. In aim 1 we will determine whether the reduced response following high dose infection is the result of the inefficient activation/expansion of cells or whether anergy and/or apoptosis is induced in responding CD8+ T cells. In aim two the contribution of antigen presenting cells to the reduced CD8+T cell response observed following high dose infection will be evaluated. The results from these studies will provide new and important information on the negative regulation of the immune response following respiratory infection and may lead to the development of novel therapeutics that can be used to boost the immune response following respiratory infection with viruses.
描述(由申请人提供):使用呼吸道病原体作为生物恐怖主义武器的威胁正在出现。因此,我们必须了解病毒病原体与肺部特殊微环境中免疫反应的相互作用。尽管许多病原体构成威胁,但特别令人担忧的是天花病毒。天花病毒感染不仅导致显着的发病率,而且导致显着的死亡率。由于天花被消灭,疫苗于 1973 年停止使用,使 30 岁以下的人得不到保护。此外,人们对免疫接种后保护持续时间的长短也存在重大担忧,因此老年人也可能容易受到感染和疾病。令人惊讶的是,尽管开发出了针对天花病毒的有效疫苗,但我们对该病毒与宿主免疫反应相互作用的基本理解仍然存在许多问题。我们开发了一种牛痘病毒呼吸道感染模型,牛痘病毒与天花疫苗中使用的病毒密切相关。本申请研究的一个优点是,它们关注鼻内感染后的免疫反应、获得天花病毒的自然途径以及生物恐怖主义制剂的可能接种途径。本申请中的研究建立在我们发表的新观察结果的基础上,即与接受少 100 倍病毒的小鼠相比,鼻内感染高剂量牛痘病毒的小鼠后 CD8+T 细胞反应严重降低。本文提出的研究目标是确定导致 T 细胞反应减弱的机制。在目标 1 中,我们将确定高剂量感染后反应减弱是否是细胞活化/扩增效率低下的结果,或者是否在响应的 CD8+ T 细胞中诱导了无反应性和/或凋亡。在目标二中,将评估抗原呈递细胞对高剂量感染后观察到的 CD8+T 细胞反应减少的贡献。这些研究的结果将为呼吸道感染后免疫反应的负调节提供新的重要信息,并可能导致开发出可用于增强呼吸道病毒感染后免疫反应的新型疗法。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus.
痘苗病毒呼吸道感染后剂量依赖性淋巴细胞凋亡。
- DOI:
- 发表时间:2008-11
- 期刊:
- 影响因子:5
- 作者:Yates, Nicole L;Yammani, Rama D;Alexander
- 通讯作者:Alexander
Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.
成熟树突状细胞的痘苗病毒感染导致病毒特异性幼稚 CD8 T 细胞的激活:直接呈递的潜在机制。
- DOI:
- 发表时间:2007-03-15
- 期刊:
- 影响因子:3.7
- 作者:Yates, Nicole L;Alexander
- 通讯作者:Alexander
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martha Ann Alexander-Miller其他文献
Martha Ann Alexander-Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martha Ann Alexander-Miller', 18)}}的其他基金
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
开发疫苗方法以在婴儿中引发广泛保护性的流感特异性免疫反应
- 批准号:
10456073 - 财政年份:2020
- 资助金额:
$ 25.2万 - 项目类别:
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
开发疫苗方法以在婴儿中引发广泛保护性的流感特异性免疫反应
- 批准号:
10229523 - 财政年份:2020
- 资助金额:
$ 25.2万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8668895 - 财政年份:2012
- 资助金额:
$ 25.2万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8840143 - 财政年份:2012
- 资助金额:
$ 25.2万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8319130 - 财政年份:2012
- 资助金额:
$ 25.2万 - 项目类别:
Vaccination strategies to overcome immune deficiencies in neonates
克服新生儿免疫缺陷的疫苗接种策略
- 批准号:
8477124 - 财政年份:2012
- 资助金额:
$ 25.2万 - 项目类别:
Cellular Immune Responses to Respiratory Infection
对呼吸道感染的细胞免疫反应
- 批准号:
7204197 - 财政年份:2004
- 资助金额:
$ 25.2万 - 项目类别:
相似国自然基金
基于神经重编程探究电针围刺促进乳腺癌CD8+T淋巴细胞募集的抗肿瘤机制
- 批准号:82305396
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成纤维细胞分泌TGFβ1阻抑CD8+T淋巴细胞上皮向浸润在口腔白斑恶变中的作用机制及靶向干预研究
- 批准号:82301095
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
合成方法学驱动的新型靶向LCK激酶小分子抑制剂的设计、合成及抗急性T淋巴细胞白血病的作用机制研究
- 批准号:22307009
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OGT通过USP15调节细胞毒性T淋巴细胞PD-1表达及其杀伤食管鳞状细胞癌的作用机理研究
- 批准号:32301069
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活性脂质Arlm-1介导的自噬流阻滞在儿童T细胞急性淋巴细胞白血病化疗耐药逆转中的作用机制研究
- 批准号:82300182
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Delineating Functional Immunity via Image-Guided PET
通过图像引导 PET 描绘功能性免疫
- 批准号:
10581857 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Strategies to attenuate the indirect alloimmune response in encapsulated pancreatic islet transplantation
减弱封装胰岛移植中间接同种免疫反应的策略
- 批准号:
10678425 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Mechanisms of Immune Dysfunction in Oral Post-Acute Sequelae of Covid-19
Covid-19口腔急性后遗症中免疫功能障碍的机制
- 批准号:
10892624 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
A modular cell therapy platform for controlling immunological tolerance
用于控制免疫耐受的模块化细胞治疗平台
- 批准号:
10725007 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别: